Deborah Neff is the President and Chief Executive Officer, and serves on the board of directors, of Pathwork Diagnostics Inc., a company commercializing innovative molecular diagnostic tests focused in oncology. She is a veteran of the life sciences industry, with a proven track record of commercializing successful new products and building market-leading global businesses.
Deborah was previously the chief executive officer of Predicant Biosciences, founded to develop technology for use in proteomics based clinical testing. Prior to joining Predicant in 2003, Deborah served as president of BD Biosciences, (a business segment of Becton Dickinson), where she’d held a series of roles with increasing responsibilities during her 15 years at BD.
As President of BD Biosciences, she led a high growth business that developed and sold biomedical research and clinical diagnostic products worldwide, with revenues of approximately $700 million in 2003. Prior to her tenure at BD, she held various management positions at Organon-Teknika Corp. and CooperBiomedical Inc. Her career began with technical and supervisory roles in the clinical laboratory at two major medical centers in southern California.
Deborah has a BS in Physiology from UC Davis, and is a medical technologist with a specialty in blood banking, having completed graduate study in Immunohematology. She also attended executive business programs in finance, marketing and general management at Wharton, Stanford and Harvard Business Schools.
She served on the board of Advanced Medical Optics Inc, and ForteBio, and is a member of the Dean’s leadership council for the College of Biological Sciences at UC Davis.
